Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders
Details for Australian Patent Application No. 2005293820 (hide)
International Classifications
Event Publications
26 April 2007 PCT application entered the National Phase
PCT publication WO2006/040038 Priority application(s): WO2006/040038
31 May 2007 Change of Name(s) of Applicant(s), Section 104
F.Hoffmann-La Roche AG The name of the applicant has been changed to F. Hoffmann-La Roche AG
25 November 2010 Application Accepted
Published as AU-B-2005293820
24 March 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005293821-N,N'-dithenylurea derivatives used in the form of kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser